Literature DB >> 23086938

The assembly of nonadhesive fibrinogen matrices depends on the αC regions of the fibrinogen molecule.

Ivan S Yermolenko1, Oleg V Gorkun, Alexander Fuhrmann, Nataly P Podolnikova, Valeryi K Lishko, Stanislav P Oshkadyerov, Susan T Lord, Robert Ros, Tatiana P Ugarova.   

Abstract

Adsorption of fibrinogen on fibrin clots and other surfaces strongly reduces integrin-mediated adhesion of platelets and leukocytes with implications for the surface-mediated control of thrombus growth and blood compatibility of biomaterials. The underlying mechanism of this process is surface-induced aggregation of fibrinogen, resulting in the assembly of a nanoscale multilayered matrix. The matrix is extensible, which makes it incapable of transducing strong mechanical forces via cellular integrins, resulting in insufficient intracellular signaling and weak cell adhesion. To determine the mechanism of the multilayer formation, the physical and adhesive properties of fibrinogen matrices prepared from human plasma fibrinogen (hFg), recombinant normal (rFg), and fibrinogen with the truncated αC regions (FgAα251) were compared. Using atomic force microscopy and force spectroscopy, we show that whereas hFg and rFg generated the matrices with a thickness of ∼8 nm consisting of 7-8 molecular layers, the deposition of FgAα251 was terminated at two layers, indicating that the αC regions are essential for the multilayer formation. The extensibility of the matrix prepared from FgAα251 was 2-fold lower than that formed from hFg and rFg. In agreement with previous findings that cell adhesion inversely correlates with the extensibility of the fibrinogen matrix, the less extensible FgAα251 matrix and matrices generated from human fibrinogen variants lacking the αC regions supported sustained adhesion of leukocytes and platelets. The persistent adhesiveness of matrices formed from fibrinogen derivatives without the αC regions may have implications for conditions in which elevated levels of these molecules are found, including vascular pathologies, diabetes, thrombolytic therapy, and dysfibrinogenemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086938      PMCID: PMC3516744          DOI: 10.1074/jbc.M112.410696

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.

Authors:  S Yakovlev; E Makogonenko; N Kurochkina; W Nieuwenhuizen; K Ingham; L Medved
Journal:  Biochemistry       Date:  2000-12-26       Impact factor: 3.162

2.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides.

Authors:  Z Yang; I Mochalkin; R F Doolittle
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 3.  The structure and function of the alpha C domains of fibrinogen.

Authors:  J W Weisel; L Medved
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

4.  Structural organization of the fibrin(ogen) alpha C-domain.

Authors:  Galina Tsurupa; Latchezar Tsonev; Leonid Medved
Journal:  Biochemistry       Date:  2002-05-21       Impact factor: 3.162

5.  The non-plasmin, proteolytic origin of human fibrinogen heterogeneity.

Authors:  D Mills; S Karpatkin
Journal:  Biochim Biophys Acta       Date:  1971-10

Review 6.  Dysfibrinogenemia and thrombosis.

Authors:  Timothy Hayes
Journal:  Arch Pathol Lab Med       Date:  2002-11       Impact factor: 5.534

7.  Accumulation of radiolabelled platelets and fibrin on the carotid artery of rabbits after angioplasty: effects of heparin and dipyridamole.

Authors:  Joanne van Ryn; Martin Lorenz; Herbert Merk; Michael R Buchanan; Wolfgang G Eisert
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

8.  Abnormal fibrinogen heterogeneity and fibrinolytic activity in advanced liver disease.

Authors:  B Lipinski; I Lipinska; A Nowak; V Gurewich
Journal:  J Lab Clin Med       Date:  1977-07

9.  Fibrinogen heterogeneity in cancer, in occlusive vascular disease, and after surgical procedures.

Authors:  I Lipinska; B Lipinski; V Gurewich; K D Hoffmann
Journal:  Am J Clin Pathol       Date:  1976-12       Impact factor: 2.493

10.  Regulated unmasking of the cryptic binding site for integrin alpha M beta 2 in the gamma C-domain of fibrinogen.

Authors:  Valeryi K Lishko; Bohdan Kudryk; Valentin P Yakubenko; Vivien C Yee; Tatiana P Ugarova
Journal:  Biochemistry       Date:  2002-10-29       Impact factor: 3.162

View more
  8 in total

1.  Deposition of fibrinogen on the surface of in vitro thrombi prevents platelet adhesion.

Authors:  Hadil Owaynat; Ivan S Yermolenko; Ramya Turaga; Valeryi K Lishko; Michael R Sheller; Tatiana P Ugarova
Journal:  Thromb Res       Date:  2015-10-09       Impact factor: 3.944

2.  Modification of Extracellular Matrix by the Product of DHA Oxidation Switches Macrophage Adhesion Patterns and Promotes Retention of Macrophages During Chronic Inflammation.

Authors:  Jared L Casteel; Kasey R Keever; Christopher L Ardell; David L Williams; Detao Gao; Eugene A Podrez; Tatiana V Byzova; Valentin P Yakubenko
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

3.  Ranking reactive glutamines in the fibrinogen αC region that are targeted by blood coagulant factor XIII.

Authors:  Kelly Njine Mouapi; Jacob D Bell; Kerrie A Smith; Robert A S Ariëns; Helen Philippou; Muriel C Maurer
Journal:  Blood       Date:  2016-03-07       Impact factor: 22.113

4.  Combined single cell AFM manipulation and TIRFM for probing the molecular stability of multilayer fibrinogen matrices.

Authors:  W Christenson; I Yermolenko; B Plochberger; F Camacho-Alanis; A Ros; T P Ugarova; R Ros
Journal:  Ultramicroscopy       Date:  2013-10-19       Impact factor: 2.689

5.  Fibrinogen matrix deposited on the surface of biomaterials acts as a natural anti-adhesive coating.

Authors:  Roman Safiullin; Wayne Christenson; Hadil Owaynat; Ivan S Yermolenko; Marsil K Kadirov; Robert Ros; Tatiana P Ugarova
Journal:  Biomaterials       Date:  2015-07-14       Impact factor: 12.479

6.  Spatially selective surface platforms for binding fibrinogen prepared by particle lithography with organosilanes.

Authors:  Lauren E Englade-Franklin; Chamarra K Saner; Jayne C Garno
Journal:  Interface Focus       Date:  2013-06-06       Impact factor: 3.906

7.  Morphometric characterization of fibrinogen's αC regions and their role in fibrin self-assembly and molecular organization.

Authors:  Anna D Protopopova; Rustem I Litvinov; Dennis K Galanakis; Chandrasekaran Nagaswami; Nikolay A Barinov; Alexander R Mukhitov; Dmitry V Klinov; John W Weisel
Journal:  Nanoscale       Date:  2017-09-21       Impact factor: 7.790

Review 8.  Protein corona: a new approach for nanomedicine design.

Authors:  Van Hong Nguyen; Beom-Jin Lee
Journal:  Int J Nanomedicine       Date:  2017-04-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.